NasserHHannaMD

Clinical Trials

• Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Start of enrollment: 2006 Feb 23

  Completed

  Phase 2

• Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer Start of enrollment: 2002 Feb 01

  Completed

  Phase 3

• Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Start of enrollment: 2005 May 01

  Completed

  Phase 1, Phase 2

• Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer Start of enrollment: 2005 Jan 01

  Terminated

  Phase 2

• A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer Start of enrollment: 2006 Apr 01

  Completed

  Phase 2

• Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas Start of enrollment: 2006 Apr 01

  Completed

  Phase 2

• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01

  Active, not recruiting

  Phase 3

• Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer Start of enrollment: 2006 Aug 01

  Completed

  Phase 2

• Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer Start of enrollment: 2006 Oct 01

  Completed

  Phase 1, Phase 2

• Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer Start of enrollment: 2007 Jun 01

  Terminated

  Phase 1, Phase 2

• Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01

  Completed

  Phase 2

• Sutent + Taxol for Advanced Esophageal Cancer Start of enrollment: 2008 Aug 01

  Completed

  Phase 2

• Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer Start of enrollment: 2009 Jan 01

  Terminated

  Phase 2

• Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2010 Sep 21

  Active, not recruiting

  Phase 2

• Telephone Support Program for Lung Cancer Patients and Their Family Caregivers Start of enrollment: 2013 Mar 01

  Completed

  Not Applicable

• Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25

  Completed

  Phase 2

• Join now to see all